Tech Company Financing Transactions
VIA Pharmaceuticals Funding Round
Bay City Capital and private investors participated in a $38.3 million capital raise for VIA Pharmaceuticals. The financing was announced on 6/30/2007.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$38,284,000
Round
Undisclosed
Investors
Bay City Capital (Fred Craves)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
750 Battery St. 330
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Website
Email Address
Overview
VIA Pharmaceuticals is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA's lead product candidate, VIA-2291, is in two Phase II clinical studies in patients with acute coronary syndrome and patients with carotid artery disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Cohen
VP - Finance
Karen Wright
VP - R & D
Tilmann Brotz
VP - R & D
Rebecca Taub
Browse more venture capital transactions:
Prev: 6/30/2007: Voicestar venture capital transaction
Next: 6/30/2007: MongoNet venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs